Neil Atkins

Neil Atkins

Auto-generated profile, based on publicly available information

Neil Atkins

Blood Pressure Unit, Beaumont Hospital, Dublin, Ireland

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2005 in Hypertension
Verified
Journal Article
Closed access
PDF file
EDEamon Dolan
Eamon Dolan
ASAlice Stanton
Alice Stanton
LTLut Thijs
Lut Thijs
KHKareem Hinedi
Kareem Hinedi
NANeil Atkins
Neil Atkins
EOEoin O’brien
Eoin O’brien
The purpose of this study was to determine if ambulatory blood pressure measurement predicted total and cardiovascular mortality over and beyond clinic blood pressure measurement and other cardiovascular risk factors; 5292 untreated hypertensive patients referred to a single blood pressure clinic who had clinic and ambulatory blood pressure measurement at baseline were followed up in a prospective study of mortality outcome. Multiple Cox regression was used to model time to total and cause-specific mortality for ambulatory blood pressure measurement while adjusting for clinic blood pressure measurement and other risk factors at baseline. There were 646 deaths (of which 389 were cardiovascular) during a median follow-up period of 8.4 years. With adjustment for gender, age, risk indices, and clinic blood pressure, higher mean values of ambulatory blood pressure were independent predictors for cardiovascular mortality. The relative hazard ratio for each 10-mm Hg increase in systolic blood pressure was 1.12 (1.06 to 1.18; P <0.001) for daytime and 1.21 (1.15 to 1.27; P <0.001) for nighttime systolic blood pressure. The hazard ratios for each 5-mm Hg increase in diastolic blood pressure were 1.02 (0.99 to 1.07; P =NS) for daytime and 1.09 (1.04 to 1.13; P <0.01) for nighttime diastolic pressures. The hazard ratios for nighttime ambulatory blood pressure remained significant after adjustment for daytime ambulatory blood pressure. These results have 2 important clinical messages: ambulatory measurement of blood pressure is superior to clinic measurement in predicting cardiovascular mortality, and nighttime blood pressure is the most potent predictor of outcome.

1 July 1990 in Journal Of Hypertension
Verified
Journal Article
Closed access
EOEoin O'Brien
Eoin O'Brien
JPJames Petrie
James Petrie
WLWilliam Littler
William Littler
MSMichael de Swiet
Michael de Swiet
PPPaul L. Padfield
Paul L. Padfield
NANeil Atkins
Neil Atkins
With the increasing manufacture of expensive systems for the measurement of ambulatory blood pressure there is a need for potential purchasers to be able to satisfy themselves that the systems have been evaluated according to agreed criteria. The British Hypertension Society has, therefore, drawn up a protocol of requirements for the evaluation of these devices. This protocol incorporates many features of the American National Standard for Non-Automated Sphygmomanometers but includes many additional features, such as strict criteria for observer training, interdevice variability testing before and after a month of ambulatory use, and a new system of analysis which permits the test system to be graded. It is recommended that manufacturers of ambulatory blood pressure measuring devices should obtain an unbiased evaluation according to a recognized standard before a device is marketed.

1 February 2010 in Blood Pressure Monitoring
Verified
Journal Article
Closed access
EOEoin O'Brien
Eoin O'Brien
NANeil Atkins
Neil Atkins
GSGeorge Stergiou
George Stergiou
NKNikos Karpettas
Nikos Karpettas
GPGianfranco Parati
Gianfranco Parati
ASAndrew Shennan
Andrew Shennan

1 March 2018 in Hypertension
Verified
Journal Article
Closed access
PDF file
GSGeorge Stergiou
George Stergiou
BABruce Alpert
Bruce Alpert
SMStephan Mieke
Stephan Mieke
RARoland Asmar
Roland Asmar
NANeil Atkins
Neil Atkins
EOEoin O’bRien
Eoin O’bRien
In the past 30 years, several organizations, such as the US Association for the Advancement of Medical Instrumentation (AAMI), the British Hypertension Society, the European Society of Hypertension (ESH) Working Group on Blood Pressure (BP) Monitoring, and the International Organization for Standardization (ISO), have developed protocols for clinical validation of BP measuring devices. However, it is recognized that science, as well as patients, consumers, and manufacturers, would be best served if all BP measuring devices were assessed for accuracy according to an agreed single validation protocol that had global acceptance. Therefore, an international initiative was taken by the AAMI, ESH, and ISO experts who agreed to develop a universal standard for device validation. This statement presents the key aspects of a validation procedure, which were agreed by the AAMI, ESH, and ISO representatives as the basis for a single universal validation protocol. As soon as the AAMI/ESH/ISO standard is fully developed, this will be regarded as the single universal standard and will replace all other previous standards/protocols.

1 March 2006 in Hypertension
Verified
Journal Article
Closed access
PDF file
EDEamon Dolan
Eamon Dolan
LTLutgarde Thijs
Lutgarde Thijs
YLYan Li
Yan Li
NANeil Atkins
Neil Atkins
PMPatricia McCormack
Patricia McCormack
ASAlice V. Stanton
Alice V. Stanton
We hypothesized that the dynamic relation between diastolic and systolic blood pressure over 24 hours provides a measure of arterial stiffness and might, therefore, predict cardiovascular mortality over and above pulse pressure. At baseline, while not on antihypertensive medication, 11 291 patients (mean age, 54.6 years; 5965 women) underwent ambulatory blood pressure monitoring. Using all of the blood pressure readings, we plotted diastolic against systolic blood pressure from each individual and calculated the regression slope. The ambulatory arterial stiffness index (AASI) was defined as 1 minus this regression slope. Over a median follow-up of 5.3 years, 566 cardiovascular deaths occurred, including 151 from stroke and 358 from cardiac disorders. Before and after adjustment for other cardiovascular risk factors, AASI and pulse pressure significantly predicted total cardiovascular mortality. AASI was a stronger predictor than pulse pressure for stroke (mutually adjusted relative hazard ratios for 1 SD increase, 1.21 versus 1.04; P =0.02 versus 0.66) with the opposite trend for cardiac mortality (relative hazard ratios, 1.03 versus 1.21; P =0.63 versus 0.002). In subjects with normal daytime ambulatory blood pressure (<135/<85 mm Hg), AASI was more predictive than pulse pressure of cardiovascular mortality (1.26 versus 0.96; P =0.04 versus 0.70) and of stroke mortality (1.81 versus 1.12; P =0.007 versus 0.58), whereas neither independently predicted cardiac mortality (1.11 versus 0.89; P =0.47 versus 0.40). AASI is a novel measure of arterial stiffness, which can be readily determined from ambulatory blood pressure recordings and which independently predicts cardiovascular mortality, even in normotensive subjects.

1 June 1993 in Journal Of Hypertension
Verified
Journal Article
Closed access
EOE O'Brien
E O'Brien
JPJ Petrie
J Petrie
WLW Littler
W Littler
MSM De Swiet
M De Swiet
PPP L Padfield
P L Padfield
NAN Atkins
N Atkins
An abstract is unavailable. This article is available as a PDF only.